Apnimed’s AD109: Revolutionizing Obstructive Sleep Apnea with Oral Neuromodulation
Apnimed’s AD109 offers a novel oral therapy for obstructive sleep apnea, targeting neurobiology for a more effective, patient‑friendly cure.
2 minutes to read
Apnimed Inc